Skip to content
thestock.space

As of 6 Nov 2026, Indo Us Biotech trades at 11.5× trailing earnings, below the industry P/E of 14.4×, and the shares are 59% below their 52-week high. It earns ROCE of 17% and ROE of 15%, and sales and net profit grew 21% and 22% a year over 3 years. Debt is 0.40× equity. It is a small-cap company with a market cap of ₹131 Cr, ranked 50th of 72 Agricultural Inputs companies by market cap; the shares fell 51% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹65.00
Day high
₹66.98
Day low
₹64.43
Prev. close
₹66.57
Volume
4.9K

Health check

2 good · 1 fair · 3 to check
  • ReturnsBehind

    −50.9% over a year, better than 1 of 7 peers.

  • Price tagCheaper

    P/E 11.5 vs industry 14.4.

  • GrowthStrong

    Sales +21.4%, profit +21.9% a year over 3 years.

  • ProfitabilityAverage

    ROCE 17.2% vs peer median 20.9%.

  • Balance sheetStretched

    Debt 0.40× equity, interest covered 7.5×, Piotroski 3 of 9.

  • Red flags2 to check

    Quarterly profit down 35.4% on a year ago.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Agricultural Inputs

71 listed peers. Screen the industry

Small cap

₹131 Cr, #50 of 72 in its industry by size.

Defensive

Beta 0.35 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹113 Cr · profit ₹11 Cr
Market cap
₹131 Cr
Small cap
P/E
11.5
Industry 14.4
Price to book
1.42
Peers 4.28
Dividend yield
0.00%
ROE
15.3%
Peers 16.2%
ROCE
17.2%
Peers 20.9%
Debt to equity
0.40
Debt ₹37 Cr
EPS (TTM)
₹5.70
Face value ₹10
OPM (TTM)
13.8%
Net margin 10.2%
Sales growth
+7.2%
Latest quarter vs a year ago
Profit growth
−35.4%
Latest quarter vs a year ago
Price to sales
1.16
EV/EBITDA 10.4

Strengths and risks

Risks to check

  • Quarterly profit down 35.4% on a year ago.
  • 59% below its 52-week high.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Indo Us Biotech

Indo Us Bio-Tech Limited engages in the production, processing, packing, and marketing of seeds in India. The company offers vegetable seeds, such as tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber, cabbage, radish, sponge gourd, pepper, chilly, sweet pepper, beet root, cow pea, corriander, onion, watermelon, musk melon, and flower seeds; cotton seeds; and oil seeds, including castor, groundnut, sesamum,…

Headquarters
Ahmedabad
Sector
Basic Materials
ISIN
INE250Z01010
Website
indousagriseeds.com

Price range

52 weeks

₹57.50₹159.00

Today

₹64.43₹66.98
Avg volume (3M)
19.1K
1-year return
minus 50.9%
From 52-week high
minus 58.9%

Peers · Agricultural Inputs

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
COROMANDELCoromandel International1,824.00minus 4.00%53,72434.517.020.9%9.4%0.1110.2%minus 12.4%
FACTFertilisers and Chemicals Travancore750.25minus 1.24%48,547–703.514.2%0.0%2.950.0%minus 15.3%
UPLUPL534.90plus 1.60%45,21423.96.09.9%20.0%0.83−1.2%minus 28.0%
PIINDPI Industries1,735.00minus 1.98%26,32130.013.114.7%24.2%0.031.1%minus 51.9%
SUMICHEMSumitomo Chemical India328.95plus 0.34%16,41929.421.021.0%20.3%0.02−2.6%minus 34.4%
CHAMBLFERTChambal Fertilizers & Chemicals384.70minus 0.91%15,4138.15.721.8%13.7%0.16−9.2%minus 19.4%
BAYERCROPBayer Cropscience3,316.30plus 0.48%14,90420.015.427.9%16.0%0.033.6%minus 31.7%
INDOUSIndo Us Biotech65.34minus 1.85%13111.59.517.2%13.8%0.4021.4%minus 50.9%
Median of 7 peers–−0.91%26,32126.615.420.9%16.0%0.110.0%−28.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
30.830.822.82633
25.326.718.622.829
5.54.24.23.24
17.8%13.5%18.2%12.4%12.0%
00000.1
0.50.40.80.60.7
0.20.20.20.30.3
4.83.63.22.43.1
2.4%3.0%5.3%17.1%1.3%
4.73.5323
2.351.721.490.981.51

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+21.4%
Profit CAGR 3Y
+21.9%
EPS CAGR 3Y
+20.3%
ROE
15.3%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
61.772.8104110
–+18.0%+42.6%+6.4%
52.361.784.793.3
9.411.219.117.1
15.2%15.3%18.4%15.5%
−0.1−0.10−0.1
1.11.41.42.1
0.80.81.10.9
–−0.1−0.1−0.1
7.48.816.513.9
2.0%6.3%1.6%5.7%
7.28.216.313.1
–+13.8%+97.4%minus 19.3%
3.754.118.116.54

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1020.120.120.1
44.542.758.572.5
11.614.314.837
3.47.44.53.5
69.584.597.8133
8.810.510.211.7
1.43.8–0.5
0.21.10.26.1
59.169.187.4115
69.584.597.8133

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
0.52.21.4−12.6
−6.7−2.5−0.8−1.5
6.31.2−1.520
0.10.9−0.95.9
−1.8−2.6−0.9−2.4
−1.3−0.40.6−15
––−0.5–

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company.

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you